{
    "relation": [
        [
            "id",
            "1",
            "2",
            "3",
            "4",
            "5",
            "6",
            "7",
            "8",
            "9",
            "10",
            "11",
            "12",
            "13",
            "14",
            "15",
            "16",
            "17",
            "18",
            "19",
            "20",
            "21",
            "22",
            "23",
            "24",
            "25",
            "26",
            "27",
            "28",
            "29",
            "30",
            "31",
            "32",
            "33",
            "34",
            "35",
            "36",
            "37",
            "38",
            "39",
            "40",
            "41",
            "42",
            "43",
            "44",
            "45",
            "46",
            "47",
            "48",
            "49",
            "50"
        ],
        [
            "Super pathways (with members indented)",
            "EGFR Transactivation by Gastrin53 Show member pathways EGFR-dependent Endothelin signaling events36",
            "Thyroid cancer29",
            "Signalling to ERKs53 Show member pathways Prolonged ERK activation events53 p38MAPK events53 Signalling to RAS53 Signalling to p38 via RIT and RIN53 Frs2-mediated activation53 ARMS-mediated activation53",
            "SHC1 events in ERBB2 signaling53 Show member pathways Signaling by Leptin53 ERK2 activation53 RAF phosphorylates MEK53 ERK1 activation53 GRB2 events in ERBB2 signaling53 MEK activation53 GRB2 events in EGFR signaling53 RAF activation53 SHC1 events in EGFR signaling53 ERK activation53 RAF/MAP kinase cascade53 SHC1 events in ERBB4 signaling53",
            "Bisphosphonate Pathway, Pharmacodynamics49",
            "VEGF Signaling Pathway49 Show member pathways VEGF Signaling54",
            "MAPK signaling pathway29 Show member pathways MAPK signaling pathway36",
            "Endometrial cancer29 Show member pathways Colorectal cancer29 Signal transduction PTEN pathway58 Acute myeloid leukemia29",
            "Development HGF signaling pathway58 Show member pathways Development EGFR signaling via PIP358 Development PDGF signaling via MAPK cascades58 Apoptosis and survival Anti apoptotic action of membrane bound ESR158 Signaling of Hepatocyte Growth Factor Receptor36 Neurotrophin signaling pathway29 Development EGFR signaling via small GTPases58 Development Neurotrophin family signaling58 Apoptosis and survival NGF signaling pathway58 Apoptosis and survival Role of CDK5 in neuronal death and survival58",
            "B Cell Receptor Signaling Pathway36 Show member pathways B cell receptor signaling pathway29 BCR signaling pathway36 TCR Signaling Pathway36 T cell receptor signaling pathway29",
            "Immune response Role of DAP12 receptors in NK cells58 Show member pathways Immune response CD16 signaling in NK cells58 Natural killer cell mediated cytotoxicity29",
            "Prolactin signaling pathway29 Show member pathways Prolactin Signaling Pathway36 Development Prolactin receptor signaling58 Leptin signaling pathway36",
            "Immune response Fc epsilon RI pathway58 Show member pathways VEGF - VEGF R2 Signaling Pathways52 VEGF signaling pathway29 Immune response BCR pathway58 Fc epsilon RI signaling pathway29 Fc-epsilon receptor I signaling in mast cells36",
            "Translation Insulin regulation of translation58 Show member pathways Transcription Receptor mediated HIF regulation58 Development CNTF receptor signaling58 Class IB PI3K non-lipid kinase events36 mTOR signaling pathway29 Insulin signaling pathway29 ErbB2/ErbB3 signaling events36 Development Growth hormone signaling via PI3K AKT and MAPK cascades58 Translation Regulation activity of EIF258 Regulation of lipid metabolism Insulin signaling generic cascades58 Transcription PPAR Pathway58 Cell adhesion PLAU signaling58 Recycling of eIF2-GDP53 Translation Regulation activity of EIF4F58",
            "EGFR1 Signaling Pathway36",
            "Oxytocin signaling pathway29 Show member pathways Vascular smooth muscle contraction29",
            "Toll-like receptor signaling pathway29 Show member pathways Chagas disease (American trypanosomiasis)29 Toll-like receptor signaling pathway36 Regulation of toll-like receptor signaling pathway36 Hepatitis B29",
            "HTLV-I infection29",
            "Chemokine Signaling51 Show member pathways Chemokine signaling pathway29",
            "Development Endothelin 1 EDNRA signaling58 Show member pathways Inflammatory mediator regulation of TRP channels29 Estrogen signaling pathway29 GnRH signaling pathway29 Cytoskeleton remodeling FAK signaling58 Development Endothelin 1 EDNRA transactivation of EGFR58",
            "Proteoglycans in cancer29",
            "Interferon Signaling53 Show member pathways ISG15 antiviral mechanism53 Cytokine Signaling in Immune system53 Regulation of IFNG signaling53 Interferon gamma signaling53 Antiviral mechanism by IFN-stimulated genes53",
            "FoxO signaling pathway29 Show member pathways PLK2 and PLK4 events36 Polo-like kinase signaling events in the cell cycle36",
            "Development Angiotensin activation of ERK58 Show member pathways Development EDNRB signaling58 Development ACM2 and ACM4 activation of ERK58 Cell adhesion Integrin inside out signaling58 Development G Proteins mediated regulation MARK ERK signaling58 Signal transduction IP3 signaling58 Development Angiotensin signaling via PYK258 Development EPO induced MAPK pathway58",
            "Viral carcinogenesis29",
            "Hepatitis C29",
            "Cell surface interactions at the vascular wall53 Show member pathways Tie2 Signaling53 PECAM1 interactions53",
            "Chronic myeloid leukemia29 Show member pathways Pancreatic cancer29",
            "ErbB signaling pathway29 Show member pathways ErbB receptor signaling network36 ErbB signaling pathway36 EGFR Inhibitor Pathway, Pharmacodynamics49",
            "Renal cell carcinoma29",
            "Signaling by Interleukins53 Show member pathways Interleukin-3, 5 and GM-CSF signaling53 Interleukin-1 processing53 Regulation of signaling by CBL53 Interleukin-6 signaling53 Interleukin-2 signaling53 Interleukin-7 signaling53 Interleukin receptor SHC signaling53",
            "Thyroid hormone signaling pathway29",
            "Gastrin-CREB signalling pathway via PKC and MAPK53 Show member pathways G alpha (q) signalling events53",
            "mTOR Pathway51 Show member pathways Insulin Pathway59 TGF-beta Pathway59 mTOR Pathway59",
            "Insulin receptor signalling cascade53 Show member pathways mTORC1-mediated signalling53 PKB-mediated events53 IRS-related events53 Inhibition of TSC complex formation by PKB53 IRS-mediated signalling53 IRS-related events triggered by IGF1R53 PDE3B signalling53 SHC-mediated signalling53 IRS activation53 Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)53 Energy dependent regulation of mTOR by LKB1-AMPK53 S6K1-mediated signalling53 Release of eIF4E53 IGF1R signaling cascade53 Regulation of Rheb GTPase activity by AMPK53 Signaling by Insulin receptor53 SHC-related events53 SOS-mediated signalling53 S6K1 signalling53 TOR signaling36 PI3K Cascade53 Regulation of AMPK activity via LKB153 mTOR signalling53 SHC activation53 SHC-related events triggered by IGF1R53 Signal attenuation53",
            "Apoptosis Pathway59 Show member pathways Akt Pathway59 NF-kappaB Pathway59",
            "PI3K-Akt signaling pathway29",
            "Signaling by FGFR53 Show member pathways Signaling by constitutively active EGFR53 Signaling by EGFR53 DAP12 interactions53 DAP12 signaling53 Signaling by ERBB253 Signaling by FGFR in disease53 Signaling by PDGF53 Downstream signaling of activated FGFR53 Signaling by EGFR in Cancer53 Signalling by NGF53 Downstream signal transduction53 Downregulation of ERBB2-ERBB3 signaling53 NGF signalling via TRKA from the plasma membrane53",
            "Glioma29 Show member pathways Melanoma29 Non-small cell lung cancer29 Bladder cancer29 Prostate cancer29 Signaling Pathways in Glioblastoma36",
            "Sorafenib Pharmacodynamics49 Show member pathways VEGF Pathway59 Vemurafenib Pathway, Pharmacodynamics49",
            "Downstream Signaling Events Of B Cell Receptor (BCR)53 Show member pathways Signaling by the B Cell Receptor (BCR)53 Activation of RAS in B Cells53",
            "FGFR ligand binding and activation53 Show member pathways FGFR1c and Klotho ligand binding and activation53 Signaling by FGFR2 amplification mutants53 Klotho-mediated ligand binding53 FGFR2 ligand binding and activation53 Negative regulation of FGFR signaling53 FRS2-mediated cascade53 Signaling by FGFR1 amplification mutants53 FGFR1b ligand binding and activation53 SHC-mediated cascade53 FGFR4 ligand binding and activation53 betaKlotho-mediated ligand binding53 Signaling by FGFR2 mutants53 Signaling by FGFR4 mutants53 Development FGF family signaling58 FGFR1 ligand binding and activation53 Spry regulation of FGF signaling53 FGFR2c ligand binding and activation53 FGFR2b ligand binding and activation53 Activated point mutants of FGFR253",
            "Disease53",
            "Ras signaling pathway29 Show member pathways Rap1 signaling pathway29",
            "Signaling by FGFR1 mutants53 Show member pathways Signaling by FGFR1 fusion mutants53 Signaling by FGFR mutants53",
            "Class I MHC mediated antigen processing and presentation53 Show member pathways Ubiquitin mediated proteolysis29 Antigen processing- Ubiquitination and Proteasome degradation53 Adaptive Immune System53",
            "Pathways in cancer29",
            "MicroRNAs in cancer29",
            "PI-3K cascade53 Show member pathways Downregulation of ERBB4 signaling53 AKT phosphorylates targets in the nucleus53 Signaling by SCF-KIT53 PI3K events in ERBB2 signaling53 Fc epsilon receptor (FCERI) signaling53 PI3K events in ERBB4 signaling53 Signaling by ERBB453 GAB1 signalosome53 Negative regulation of the PI3K/AKT network53 Role of LAT2/NTAL/LAB on calcium mobilization53 PIP3 activates AKT signaling53 Regulation of KIT signaling53 AKT phosphorylates targets in the cytosol53 AKT-mediated inactivation of FOXO1A53 PI3K/AKT Signaling in Cancer53 Constitutive PI3K/AKT Signaling in Cancer53 PI3K/AKT activation53",
            "Regulation of Actin Cytoskeleton36 Show member pathways Regulation of actin cytoskeleton29"
        ],
        [
            "Score",
            "8.8",
            "8.8",
            "8.8",
            "8.8",
            "8.8",
            "8.4",
            "8.4",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "8.0",
            "7.5",
            "7.5",
            "7.5",
            "7.5",
            "7.5",
            "7.5",
            "7.5",
            "7.5",
            "7.5",
            "7.5",
            "7.5",
            "7.5",
            "7.5",
            "7.5",
            "7.5",
            "7.5"
        ],
        [
            "Top Affiliating Genes",
            "KRAS, NRAS, HRAS",
            "KRAS, NRAS, HRAS",
            "HRAS, KRAS, NRAS",
            "NRAS, KRAS, HRAS",
            "NRAS, KRAS, HRAS",
            "KRAS, NRAS, HRAS, FGFR3",
            "FGFR3, KRAS, HRAS, NRAS",
            "KRAS, NRAS, HRAS, PIK3CA",
            "KRAS, HRAS, PIK3CA, NRAS",
            "PIK3CA, HRAS, KRAS, NRAS",
            "HRAS, PIK3CA, KRAS, NRAS",
            "KRAS, HRAS, NRAS, PIK3CA",
            "PIK3CA, HRAS, KRAS, NRAS",
            "HRAS, KRAS, PIK3CA, NRAS",
            "HRAS, NRAS, PIK3CA, KRAS",
            "HRAS, KRAS, NRAS, PIK3CA",
            "PIK3CA, KRAS, HRAS, NRAS",
            "HRAS, KRAS, NRAS, PIK3CA",
            "HRAS, PIK3CA, NRAS, KRAS",
            "HRAS, PIK3CA, KRAS, NRAS",
            "NRAS, HRAS, PIK3CA, KRAS",
            "HRAS, KRAS, NRAS, PIK3CA",
            "HRAS, NRAS, KRAS, PIK3CA",
            "HRAS, KRAS, NRAS, PIK3CA",
            "PIK3CA, KRAS, HRAS, NRAS",
            "HRAS, KRAS, NRAS, PIK3CA",
            "HRAS, PIK3CA, KRAS, NRAS",
            "PIK3CA, KRAS, NRAS, HRAS",
            "HRAS, NRAS, PIK3CA, KRAS",
            "HRAS, KRAS, NRAS, PIK3CA",
            "HRAS, NRAS, KRAS, PIK3CA",
            "HRAS, NRAS, PIK3CA, KRAS",
            "NRAS, KRAS, PIK3CA, HRAS",
            "NRAS, KRAS, PIK3CA, HRAS",
            "FGFR3, HRAS, PIK3CA, KRAS, NRAS",
            "KRAS, NRAS, PIK3CA, HRAS, FGFR3",
            "KRAS, NRAS, HRAS, PIK3CA, FGFR3",
            "HRAS, FGFR3, KRAS, PIK3CA, NRAS",
            "PIK3CA, KRAS, HRAS, NRAS, FGFR3",
            "PIK3CA, NRAS, KRAS, HRAS, FGFR3",
            "FGFR3, PIK3CA, NRAS, KRAS, HRAS",
            "NRAS, PIK3CA, FGFR3, KRAS, HRAS",
            "PIK3CA, KRAS, HRAS, FGFR3, NRAS",
            "KRAS, PIK3CA, NRAS, HRAS, FGFR3",
            "KRAS, PIK3CA, NRAS, HRAS, FGFR3",
            "PIK3CA, NRAS, HRAS, FGFR3, KRAS",
            "KRAS, PIK3CA, NRAS, FGFR3, HRAS",
            "PIK3CA, HRAS, KRAS, FGFR3, NRAS",
            "FGFR3, HRAS, KRAS, NRAS, PIK3CA",
            "KRAS, HRAS, FGFR3, NRAS, PIK3CA"
        ]
    ],
    "pageTitle": "Epidermal Nevus, Somatic disease: Malacards - Research Articles, Symptoms, Drugs, Genes, Clinical Trials",
    "title": "",
    "url": "http://www.malacards.org/card/epidermal_nevus_somatic",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988458.74/warc/CC-MAIN-20150728002308-00300-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 572369919,
    "recordOffset": 572337661,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "(show all 122) (show top 50) \u00a0\u00a0 Pathways related to Epidermal Nevus, Somatic according to GeneCards Suite gene sharing: See all sources Tocris Bioscience 59 QIAGEN, 51 R&D Systems, 52 Thomson Reuters, 58 SinoBiological, 54 PharmGKB, 49 KEGG, 29 NCBI BioSystems Database, 36 Reactome, 53 PathCards, 48 Sources: Pathways for genes affiliated with Epidermal Nevus, Somatic Jump to section Aliases & Classifications Anatomical Context Animal Models Compounds Drugs & Therapeutics Expression Genes Genetic Tests GO Terms Pathways Products Publications Related Diseases Sources Summaries Symptoms Variations Top Bottom GEO for disease gene expression data for Epidermal Nevus, Somatic. Search See all sources Gene Expression",
    "textAfterTable": "Jump to section Aliases & Classifications Anatomical Context Animal Models Compounds Drugs & Therapeutics Expression Genes Genetic Tests GO Terms Pathways Products Publications Related Diseases Sources Summaries Symptoms Variations Top Bottom Compounds for genes affiliated with Epidermal Nevus, Somatic Sources: 43Novoseek, 28 IUPHAR, 12 DrugBank, 49 PharmGKB, 24 HMDB, 59 Tocris Bioscience See all sources Compounds related to Epidermal Nevus, Somatic according to GeneCards Suite gene sharing: (show all 29) id Compound Score Top Affiliating Genes 1 farnesyl diphosphate43 28 12 11.7 KRAS, HRAS 2 erlotinib43 49 12 11.4 KRAS,",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}